Table IV.
Association between Lewis y and TGF-β1 expression intensity and pathological features.
| Lewis y antigen | TGF-β1 | |||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| Features | n | MOD | P-value | n | MOD | P-value |
| Pathological type | ||||||
| Mucous | 26 | 0.463±0.068 | P>0.05 | 25 | 0.437±0.064 | P>0.05 |
| Serous | 27 | 0.477±0.016 | 22 | 0.426±0.055 | ||
| FIGO stage | ||||||
| I and IIstage | 33 | 0.455±0.065 | P<0.05 | 29 | 0.426±0.055 | P>0.05 |
| III and IV stage | 20 | 0.505±0.072 | 18 | 0.440±0.064 | ||
| Differentiation level | ||||||
| High | 17 | 0.448±0.017 | P<0.05a | 17 | 0.451±0.065 | P<0.05a |
| Middle | 18 | 0.461±0.054 | P>0.05b | 16 | 0.402±0.044 | P<0.05b |
| Low | 18 | 0.498±0.084 | P>0.05c | 14 | 0.441±0.029 | P>0.05c |
| Lymphatic metastasis | ||||||
| No | 41 | 0.459±0.078 | P>0.05 | 36 | 0.424±0.056 | P>0.05 |
| Yes | 12 | 0.476±0.057 | 11 | 0.452±0.068 | ||
a
Compared with the low-differentiation group;
b
Compared with the low-differentiation group;
c
Compared with the middle-differentiation groups.
MOD, mean optical density.